Eric D. Wieben

3.8k total citations
52 papers, 1.7k citations indexed

About

Eric D. Wieben is a scholar working on Molecular Biology, Genetics and Rheumatology. According to data from OpenAlex, Eric D. Wieben has authored 52 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 12 papers in Genetics and 6 papers in Rheumatology. Recurrent topics in Eric D. Wieben's work include RNA Research and Splicing (9 papers), RNA and protein synthesis mechanisms (6 papers) and Genomics and Rare Diseases (5 papers). Eric D. Wieben is often cited by papers focused on RNA Research and Splicing (9 papers), RNA and protein synthesis mechanisms (6 papers) and Genomics and Rare Diseases (5 papers). Eric D. Wieben collaborates with scholars based in United States, Canada and China. Eric D. Wieben's co-authors include Bruce W. Eckloff, Richard M. Weinshilboum, Thoru Pederson, Daniel J. Schaid, Oreste E. Salavaggione, Irene Moon, Liewei Wang, Linda L. Pelleymounter, Araba A. Adjei and Bianca A. Thomae and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Eric D. Wieben

52 papers receiving 1.6k citations

Peers

Eric D. Wieben
Anthony Batzler United States
Michael Podvinec Switzerland
Irene Moon United States
Donna J. Buckley United States
Yves Boie Canada
Scott J. Hebbring United States
U. Karbach Germany
Eric D. Wieben
Citations per year, relative to Eric D. Wieben Eric D. Wieben (= 1×) peers Toshihiro Tanioka

Countries citing papers authored by Eric D. Wieben

Since Specialization
Citations

This map shows the geographic impact of Eric D. Wieben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric D. Wieben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric D. Wieben more than expected).

Fields of papers citing papers by Eric D. Wieben

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric D. Wieben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric D. Wieben. The network helps show where Eric D. Wieben may publish in the future.

Co-authorship network of co-authors of Eric D. Wieben

This figure shows the co-authorship network connecting the top 25 collaborators of Eric D. Wieben. A scholar is included among the top collaborators of Eric D. Wieben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric D. Wieben. Eric D. Wieben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heldenbrand, Jacob R., Saurabh Baheti, Matthew A. Bockol, et al.. (2019). Recommendations for performance optimizations when using GATK3.8 and GATK4. BMC Bioinformatics. 20(1). 557–557. 35 indexed citations
2.
Baheti, Saurabh, Matthew A. Bockol, Travis Drucker, et al.. (2019). Sentieon DNASeq Variant Calling Workflow Demonstrates Strong Computational Performance and Accuracy. Frontiers in Genetics. 10. 736–736. 134 indexed citations
3.
Theis, Jeanne L., Michael T. Zimmermann, Brandon T. Larsen, et al.. (2014). TNNI3K mutation in familial syndrome of conduction system disease, atrial tachyarrhythmia and dilated cardiomyopathy. Human Molecular Genetics. 23(21). 5793–5804. 33 indexed citations
4.
Ellsworth, Katarzyna A., Bruce W. Eckloff, Liang Li, et al.. (2013). Contribution of FKBP5 Genetic Variation to Gemcitabine Treatment and Survival in Pancreatic Adenocarcinoma. PLoS ONE. 8(8). e70216–e70216. 37 indexed citations
5.
Ji, Yuan, Yubo Chai, Scott J. Hebbring, et al.. (2012). Human Liver Methionine Cycle: MAT1A and GNMT Gene Resequencing, Functional Genomics, and Hepatic Genotype-Phenotype Correlation. Drug Metabolism and Disposition. 40(10). 1984–1992. 15 indexed citations
6.
Yi, Peng, Linda L. Pelleymounter, Irene Moon, et al.. (2011). Methionine Adenosyltransferase 2A/2B and Methylation: Gene Sequence Variation and Functional Genomics. Drug Metabolism and Disposition. 39(11). 2135–2147. 23 indexed citations
7.
Karpyak, Victor M., Jeonghyun Kim, Joanna M. Biernacka, et al.. (2009). Sequence Variations of the Human MPDZ Gene and Association With Alcoholism in Subjects With European Ancestry. Alcoholism Clinical and Experimental Research. 33(4). 712–721. 27 indexed citations
8.
Moyer, Ann M., Oreste E. Salavaggione, Scott J. Hebbring, et al.. (2007). Glutathione S -Transferase T1 and M1: Gene Sequence Variation and Functional Genomics. Clinical Cancer Research. 13(23). 7207–7216. 58 indexed citations
9.
Ji, Yuan, Irene Moon, Jelena Zlatković, et al.. (2007). Human Hydroxysteroid Sulfotransferase SULT2B1 Pharmacogenomics: Gene Sequence Variation and Functional Genomics. Journal of Pharmacology and Experimental Therapeutics. 322(2). 529–540. 30 indexed citations
10.
Salavaggione, Oreste E., Linda L. Pelleymounter, Irene Moon, et al.. (2006). GLUTATHIONE S-TRANSFERASE OMEGA 1 AND OMEGA 2 PHARMACOGENOMICS. Drug Metabolism and Disposition. 34(7). 1237–1246. 77 indexed citations
11.
Martin, Yvette N., Oreste E. Salavaggione, Bruce W. Eckloff, et al.. (2006). Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomics. Pharmacogenetics and Genomics. 16(4). 265–277. 54 indexed citations
12.
Cynthia, X., Araba A. Adjei, Oreste E. Salavaggione, et al.. (2005). Human Aromatase: Gene Resequencing and Functional Genomics. Cancer Research. 65(23). 11071–11082. 155 indexed citations
13.
Wieben, Eric D.. (2003). Primer on Medical Genomics Part VII: The Evolving Concept of the Gene. Mayo Clinic Proceedings. 78(5). 580–587. 7 indexed citations
14.
Pardanani, Animesh, Eric D. Wieben, Thomas C. Spelsberg, & Ayalew Tefferi. (2002). Primer on Medical Genomics Part IV: Expression Proteomics. Mayo Clinic Proceedings. 77(11). 1185–1196. 15 indexed citations
15.
Lorentz, Cindy Pham, Eric D. Wieben, Ayalew Tefferi, David Whiteman, & Gordon W. Dewald. (2002). Primer on Medical Genomics Part I: History of Genetics and Sequencing of the Human Genome. Mayo Clinic Proceedings. 77(8). 773–782. 15 indexed citations
16.
Atanasova, Elena, SHARON A. CHIAPPA, Eric D. Wieben, & Stephen Brimijoin. (1999). Novel Messenger RNA and Alternative Promoter for Murine Acetylcholinesterase. Journal of Biological Chemistry. 274(30). 21078–21084. 25 indexed citations
17.
Tichelaar, Jay W., Birgit Knerer, Anne M. Vrabel, & Eric D. Wieben. (1994). Transcription of a Variant Human U6 Small Nuclear RNA Gene Is Controlled by a Novel, Internal RNA Polymerase III Promoter. Molecular and Cellular Biology. 14(8). 5450–5457. 4 indexed citations
18.
Girard, Benoît, Diane M. Otterness, Thomas C. Wood, et al.. (1994). Human histamine N-methyltransferase pharmacogenetics: cloning and expression of kidney cDNA.. Molecular Pharmacology. 45(3). 461–468. 28 indexed citations
19.
Neiswanger, Katherine, David R. Stanford, R S Sparkes, et al.. (1990). Assignment of the gene for the small nuclear ribonucleoprotein E (SNRPE) to human chromosome 1q25–q43. Genomics. 7(4). 503–508. 6 indexed citations
20.
Moore, John T., Jaana Hagström, Daniel McCormick, et al.. (1987). The major clotting protein from guinea pig seminal vesicle contains eight repeats of a 24-amino acid domain.. Proceedings of the National Academy of Sciences. 84(19). 6712–6714. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026